Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05968573 · ClinicalTrials.gov registry record · NA
Persuasive Health Communication Intervention for HIV/HCV
A NA study of Human Immunodeficiency Virus (HIV) and Hepatitis C (HCV), sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
- 1
- Study location
NCT05968573 is a NA study of Human Immunodeficiency Virus (HIV) and Hepatitis C (HCV) that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 2,000 participants, above the 398-participant average among 18 other Human Immunodeficiency Virus (HIV) trials with a reported enrollment target (403% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05968573, a NA study of Human Immunodeficiency Virus (HIV) and Hepatitis C (HCV), is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
A major impediment to emergency department (ED)-based HIV/HCV screening success is that often ED patients at risk for, or later diagnosed with, HIV and HCV decline testing. In this R01 project, the research team will assess how well a promising, easy-to-use, one-time, minimal-training-needed, very brief persuasive health communication intervention (PHCI) increases acceptance of testing among adult ED patients who either currently, formerly or never injected drugs and initially declined HIV/HCV screening. The research team will conduct a randomized, controlled trial (RCT) at EDs within the Mount Sinai Health System to compare the efficacy of the PHCI when delivered by a video vs. an HIV/HCV counselor. Patients who initially declined HIV/HCV screening will be stratified by injection-drug use (IDU) history cohorts: (1) current/former PWIDs, (2) never/non-PWIDs. Within each IDU history cohort, the research team will randomly assign participants (1:1:1) to a PHCI delivered by: (1) a video with captions, (2) a video without captions, (3) an HIV/HCV counselor. This R01 project will be conducted at Mount Sinai affiliate hospitals EDs. For Aim 2, the research team will determine if screening acceptance is similar across IDU history cohorts. For Aim 3, the research team will further compare the two delivery forms of the PHCI through a health economics assessment, both independent of IDU history and within each IDU history cohort.
Conditions Studied
Interventions
- OTHER Video Format with Captions
- OTHER Video Format without Captions
- OTHER Health Educator
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2026-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05968573
The ClinicalTrials.gov registry entry for NCT05968573 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 398-participant average among 18 other Human Immunodeficiency Virus (HIV) trials with a reported enrollment target (403% higher). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Human Immunodeficiency Virus (HIV) appearing as the primary indexed condition, and to 3 interventions - of which Video Format with Captions is the first listed.
NCT05968573 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05968573 about?
NCT05968573 is a clinical study titled "Persuasive Health Communication Intervention for HIV/HCV". A major impediment to emergency department (ED)-based HIV/HCV screening success is that often ED patients at risk for, or later diagnosed with, HIV and HCV decline testing. In this R01 project, the research team will assess how well a promising, easy-to-use, one-time, minimal-training-needed, very b...
What is the current status of trial NCT05968573?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2023-12-04. Estimated completion is 2026-08-01.
What conditions does trial NCT05968573 study?
This clinical trial studies the following conditions: Human Immunodeficiency Virus (HIV), Hepatitis C (HCV).
What interventions are being tested in trial NCT05968573?
The interventions under investigation include: Video Format with Captions (OTHER), Video Format without Captions (OTHER), Health Educator (OTHER).
Who is sponsoring clinical trial NCT05968573?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05968573 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Immunodeficiency Virus (HIV)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Quitting Matters Human Immunodeficiency Virus Hybrid Trial
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
Project neuroARTEMIS
RECRUITING · NA
-
e-HERO: Ending the HIV Epidemic in Rural Oklahoma
RECRUITING · NA
-
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
ACTIVE NOT RECRUITING · NA
-
Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.